BIOMAT Database Logo BIOMAT Database Logo

Specific active immunotherapy in children with acute lympholastic leukemia and host immune responses against leukemic antigens. 1978

M Sakurai, and T Izawa

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

M Sakurai, and T Izawa
Active immunotherapy in leukemia with neuraminidase-modified leukemic cells.
January 1977, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
M Sakurai, and T Izawa
[Active immunotherapy with allogenic leukemic cells in complex treatment of patients with acute leukemia].
August 1978, Sovetskaia meditsina,
M Sakurai, and T Izawa
[Active immunotherapy of children with acute leukemia during complete remission].
February 1975, Problemy gematologii i perelivaniia krovi,
M Sakurai, and T Izawa
Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy.
March 2017, Journal of translational medicine,
M Sakurai, and T Izawa
Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia.
January 1978, Cancer,
M Sakurai, and T Izawa
Antibody responses of remission leukemia patients receiving active specific and nonspecific immunotherapy.
January 1981, Cancer,
M Sakurai, and T Izawa
Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.
September 2001, Journal of clinical pathology,
M Sakurai, and T Izawa
Active specific immunotherapy against adenocarcinomas.
January 1994, Cancer investigation,
M Sakurai, and T Izawa
Active specific immunotherapy of renal cell carcinoma: cellular and humoral immune responses.
June 1997, Cancer biotherapy & radiopharmaceuticals,
M Sakurai, and T Izawa
Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia.
July 2013, Leukemia & lymphoma,
Copied contents to your clipboard!